Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Kanamycin

An aminoglycoside antibiotic isolated in 1957 by the Japanese microbiologist Hamao Umezawa from the bacterium Streptomyces kanamyceticus: it is active against many Gram-negative bacteria and the tuberculosis bacillus. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?In molecular biology it is a classic: the KanR resistance gene, which disables the antibiotic by adding a phosphate group to it, is used to select bacteria that have taken up a plasmid.

Kanamycin BPharmacopoeial impurityKanamycin BCat. No. P-K002-010CAS 4696-76-8
Kanamycin DImpurityKanamycin DCat. No. P-K002-012CAS 31077-69-7

EDQM standards 2

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.